Generation Bio Co. — Investor Relations & Filings
Generation Bio Co. is a biotechnology company developing therapeutics for T cell-driven autoimmune diseases. The company's platform utilizes proprietary cell-targeted lipid nanoparticles (ctLNPs) to selectively deliver small interfering RNA (siRNA) to T cells. This approach is designed to potently silence specific genes and modulate the function of autoreactive T cells responsible for tissue and organ damage. The technology aims to provide redosable treatments with genetic precision and tunable pharmacology, while sparing the broader immune system from off-target effects.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| SCHEDULE 13G/A Filing | 2026-02-17 | English | |
| SCHEDULE 13G/A Filing | 2026-02-12 | English | |
| SCHEDULE 13G/A Filing | 2026-02-11 | English | |
| 4 - Generation Bio Co. (0001733294) (Issuer) | 2026-02-10 | English | |
| 4 - Generation Bio Co. (0001733294) (Issuer) | 2026-02-09 | English | |
| 4 - Generation Bio Co. (0001733294) (Issuer) | 2026-02-09 | English |
Browse filings by year
8 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Ernexa Therapeutics Inc.
Biopharmaceutical company developing cell therapies for can…
|
ERNA | US | Manufacturing |
|
ERYTECH Pharma S.A.
Develops red blood cell-based therapies for cancer and orph…
|
ERYP | FR | Manufacturing |
|
Esperion Therapeutics, Inc.
Develops and commercializes oral medicines to reduce cardio…
|
ESPR | US | Manufacturing |
|
ESSA Pharma Inc.
Develops drugs targeting the androgen receptor's N-terminal…
|
EPIX | US | Manufacturing |
|
Essex Bio-Technology Limited
Develops and manufactures biologic drugs using recombinant …
|
1061 | HK | Manufacturing |
|
Estrella Immunopharma, Inc.
Clinical-stage biopharma developing T-cell immunotherapies …
|
ESLA | US | Manufacturing |
|
Eton Pharmaceuticals, Inc.
Pharmaceutical company developing and commercializing treat…
|
ETON | US | Manufacturing |
|
EuBiologics Co., Ltd.
A biopharmaceutical company developing vaccines and offerin…
|
206650 | KR | Manufacturing |
|
Eupraxia Pharmaceuticals Inc.
Clinical-stage biotech developing targeted extended-release…
|
EPRX | CA | Manufacturing |
|
EUPRAXIA PHARMACEUTICALS INC.
Clinical-stage biotech developing locally delivered, extend…
|
EPRX | CA | Manufacturing |
Generation Bio Co. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34688/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34688 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34688 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34688 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34688}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Generation Bio Co. (id: 34688)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.